Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis

Table 3

PSE tissue thickness.

Layer	Time	Layer thickness (mm)
Treatment		Ctrl	0.5 mM A	3 mM A	3 mM G	3 mM A+G	100 nM VitD
Stratum corneum	2 days	0.02	0.05	0.02	0.15	0.05	0.05
	6 days	0.15	0.05	0.1	N/D	0.1	0.2
Epidermis	2 days	0.1	0.1	0.1	0.2	0.1	0.15
	6 days	0.2	0.1	0.15	N/D	0.15	0.2
Dermis	2 days	0.2	0.4	0.25	0.3	0.3	0.25
	6 days	0.2	0.25	0.35	N/D	0.25	0.2